The Agenda
Download Full Agenda
Why Attend
The 3D Cell Models Congress 2018 will present the latest developments and innovation in three-dimensional cell models including organoids, spheroids, and organ-on-a-chip, as well as bioprinting technologies.
Leading pharma and biotech companies and top academics will present their data on the applicability of 3D models in drug safety testing, disease modelling, personalized medicine, drug discovery and more.
The regulatory hurdles for the widespread implementation of these models will be addressed by the EMA and the FDA, allowing you to more effectively progress in your research. Dedicated networking sessions will facilitate collaborations to drive forward superior drug and therapeutic development.
The Speakers
Dr. Uwe Marx
Trained in human biology and medicine, Dr. Marx is an accomplished entrepreneur and the scientific founder of TissUse, a spin-off of the Institute of Biotechnology of the Technische Universität Berlin, Germany. Over the course of his fruitful career in biotechnology, Dr. Marx has pursued ever more lifelike structures that can mimic human biology in vitro. Prior to founding TissUse, Dr. Marx was head of the “Multi-Organ-Chip” program at the University and the scientific co-founder at two successful Germany-based biotechs, ProBioGen AG and VITA 34.
Philip Hewitt
Magnus Ingelman-Sundberg
Dr. Suzanne Fitzpatrick
Tommy Andersson
Robert Vries
Dr. Sonja Beken
Professor Paul Gatenholm
Josep Samitier
Dr. Yu Shrike Yang
Adrian Britschgi
Olivier Guenat
Prof. Gabor Forgacs
Dr. Hansjoerg Keller
Gianni Dal Negro
Dr Noushin Dianat
Being a liver bioengineering enthusiast, in 2014, Noushin joined Laboratory of Colloids and Divided Materials (LCMD) at ESPCI Paris (The City of Paris Industrial Physics and Chemistry Higher Educational Institution) as a postdoctoral fellow and developed a novel 3D liver model adapted for high throughput drug screening through a collaborative project with Sanofi.
Dr. Peter Loskill
Dr. Peter Loskill is Assistant Professor for Experimental Regenerative Medicine at the Eberhard Karls University Tübingen and head of the Fraunhofer Attract group Organ-on-a-Chip at the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB) in Stuttgart, Germany. Dr. Loskill graduated in 2012 from Saarland University with a PhD in Physics focusing on Biointerface science.
Dr. Sébastien Cadau
Dr. Andrew Mearns Spragg
Dr. Reyk Horland
Prof. James Hickman
Event Partners
Organovo
Website: www.organovo.com
Organovo designs and creates functional 3D bioprinted tissues for use in drug discovery, clinical development, and therapeutic applications. The Company develops 3D human tissue systems through internal research programs and in collaboration with pharmaceutical, academic and other partners. Organovo's 3D human tissues have the potential to transform the drug discovery process, enabling treatments to be developed more effectively and with greater relevance to performance in human trials and commercialization.
The Company’s ExVive™ Human Liver and Kidney Tissues are commercially available through its NovoView™ Preclinical Testing Services and are used in high-value drug profiling, including compound screening in disease models, toxicology, target and marker discovery/validation, and other drug testing. The Company is also advancing a preclinical program to develop liver therapeutic tissues for critical unmet medical needs, including certain life-threatening pediatric diseases.
Jellagen
Website: http://www.jellagen.co.uk/
Jellagen Ltd is a marine biotechnology company manufacturing next generation Collagen Type 0 for medical and scientific research applications. Our strategic mission is to commercialize marine sourced Collagen Type 0 based upon its many advantages over mammalian sources, while also exploring new therapeutic opportunities which arise from the unique qualities of Collagen Type 0 as a biomaterial. The Jellagen business model is based upon our deep belief in building sustainable sources for critical biomaterials which do not carry the environmental and human health risks of traditional collagen sources. Our research and development strategy focuses on establishing partnerships with medical institutions of the highest reputation to investigate the use of Collagen Type 0 as a treatment for skin diseases and as a biomaterial for tissue reconstruction.
Founded in Cardiff, Wales in 2015, Jellagen is already marketing a range of next generation Collagen Type 0 products for research use, while also developing clinical grade formulations for therapeutic and medical device applications. Based on the pioneering research of Professor Andrew Mearns Spragg, collagen in Jellagen’s products is extracted from Rhizostoma pulmo, an ancient species of large jellyfish common to the Irish Sea. Peer-reviewed published research as well as the company’s own application specific advisory papers demonstrate the significant advantages of Collagen Type 0 over mammalian collagen for both research and medical uses.
Media Partners
3D Med Net
Website: https://www.3dmednet.com/
3DMedNet is a network that unites all members of the diverse community in 3D printing and bioprinting. We enable the connection and collaboration between a multidisciplinary mix of experts, from regulators and manufacturers to surgeons and bioengineers that will help this exciting field move forward at an even faster rate.
Bioprocess International Magazine
Website: http://www.bioprocessintl.com/
BioProcess International magazine covers the whole bioprocessing industry: biotherapeutic process and product development and biomanufacturing.
Technology Networks
Website: https://www.technologynetworks.com/
Technology Networks is an internationally recognised publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discovery and analytical arenas.
Biocompare
Website: https://www.biocompare.com/
Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.
Drug Target Review
Website: https://www.drugtargetreview.com/
From the industry experts and publishing team behind European Pharmaceutical Review, Drug Target Review provides a voice for the drug discovery industry, promoting the latest research and developments, funding projects, and cutting-edge technological developments.
Drug Target Review’s quarterly magazine, website and annual events programme provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. 90% of our readers would recommend Drug Target Review to a friend or colleague.
PARTNER WITH US
Based on your objectives, we can create bespoke packages designed specifically for you. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding, and Networking.
Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]
Venue
Mövenpick Hotel,Schöneberger Str. 3, 10963, Berlin, Germany
Movenpick Hotel Berlin, Schoeneberger Strasse 3, 10963 Berlin, Germany
Rate: €119.00 includes vat and buffet breakfast, single occupancy. To book a room telephone reservations + 49 (0) 30 23 006 186 or Email: [email protected]
For online reservations please visit the Group Reservations page
Always quote “KISACO RESEARCH LTD” when booking.
If you need to book more than two nights please contact the hotel directly and quote our code.
Mövenpick Hotel Berlin is a 4-star hotel located in the city centre of Berlin near the Anhalter Bahnhof S-Bahn train station and Berlin’s famous public square, Potsdamer Platz.
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Book a Team to Save More!
PLEASE NOTE: Team Discounts are only available for Industry Pricing
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
Payment Terms for 3D Cell Models Congress:
- Please note that a €49 processing fee will apply to any invoices requested.
- All Prices are in EUR and are exclusive of VAT @ 19%
- All Early Bird discount prices, including Group Discounts, must be paid in full by deadlines provided above.
- No discounts or offers can be combined with any other offer.
- Please view our Cancellation Policy.
- QUESTIONS? Please email [email protected].
Pass Features:
- 3D Cell Models Congress - Access to all areas
- Networking Sessions
- Lunch and Refreshments
Complimentary Articles and Content
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.